Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/1736

TR 383 Mouse Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                  1-AMINO-2,4-DIBROMOANTHRAQUINONE


NTP Experiment-Test: 05061-02                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 05/19/95
Route: DOSED FEED                                                                                                 Time: 16:49:58




       Facility:  TSI Mason Research

       Chemical CAS #:  81-49-2

       Lock Date:  03/25/92

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05061-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  1-AMINO-2,4-DIBROMOANTHRAQUINONE                             Date: 05/19/95  
Route: DOSED FEED                                                                                                 Time: 16:49:58  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        UNTREATE     1.0%         2.0%                                                   
                                                   D 71UF       71LF         71HF                                                   
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           60           60                                                  
  Scheduled Sacrifice                                 10           10           10                                                  
  Early Deaths                                                                                                                      
    Moribund                                           5           11           11                                                  
    Dead                                               6            5            6                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                38           33           33                                                  
    Moribund                                           1                                                                            
    Dead                                                            1                                                               
  Animals Examined Microscopically                    60           60           60                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (60)         (55)         (57)                                                
      Autolysis                                                                  1 (2%)                                             
   Gallbladder                                        (59)         (57)         (54)                                                
      Autolysis                                        3 (5%)       2 (4%)       2 (4%)                                             
      Inflammation, Chronic                            1 (2%)                    1 (2%)                                             
      Inflammation, Chronic Active                     6 (10%)      6 (11%)      8 (15%)                                            
      Epithelium, Hyperplasia                                       1 (2%)                                                          
   Intestine Large, Colon                             (60)         (60)         (58)                                                
      Autolysis                                        3 (5%)       1 (2%)                                                          
      Inflammation, Acute                                           1 (2%)                                                          
      Peyer's Patch, Hyperplasia                                    1 (2%)       1 (2%)                                             
   Intestine Large, Rectum                            (60)         (60)         (57)                                                
      Autolysis                                        2 (3%)       1 (2%)                                                          
      Peyer's Patch, Epithelium, Proliferation         1 (2%)                                                                       
   Intestine Large, Cecum                             (60)         (59)         (57)                                                
      Autolysis                                        4 (7%)       1 (2%)                                                          
      Peyer's Patch, Hyperplasia                       1 (2%)       2 (3%)                                                          
   Intestine Small, Duodenum                          (58)         (60)         (56)                                                
      Angiectasis                                                   1 (2%)                                                          
      Autolysis                                        2 (3%)       2 (3%)       2 (4%)                                             
   Intestine Small, Jejunum                           (57)         (60)         (56)                                                
      Autolysis                                        1 (2%)       2 (3%)       2 (4%)                                             
      Peyer's Patch, Hyperplasia                                                 2 (4%)                                             
   Intestine Small, Ileum                             (58)         (60)         (56)                                                
      Autolysis                                        2 (3%)       2 (3%)       2 (4%)                                             
      Inflammation, Acute                                           1 (2%)                                                          
      Peyer's Patch, Hyperplasia                       4 (7%)       3 (5%)       1 (2%)                                             
      Peyer's Patch, Inflammation, Acute                                         1 (2%)                                             
   Liver                                              (60)         (60)         (60)                                                
      Autolysis                                        2 (3%)                    1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05061-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  1-AMINO-2,4-DIBROMOANTHRAQUINONE                             Date: 05/19/95  
Route: DOSED FEED                                                                                                 Time: 16:49:58  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        UNTREATE     1.0%         2.0%                                                   
                                                   D 71UF       71LF         71HF                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Basophilic Focus                                              5 (8%)       6 (10%)                                            
      Clear Cell Focus                                             10 (17%)      9 (15%)                                            
      Eosinophilic Focus                                            4 (7%)       2 (3%)                                             
      Fatty Change                                     3 (5%)       4 (7%)      18 (30%)                                            
      Fibrosis                                                                   1 (2%)                                             
      Hematopoietic Cell Proliferation                 3 (5%)       6 (10%)      6 (10%)                                            
      Hemorrhage                                                                 1 (2%)                                             
      Inflammation, Acute                                           5 (8%)       4 (7%)                                             
      Inflammation, Chronic Active                    36 (60%)     28 (47%)     29 (48%)                                            
      Mixed Cell Focus                                              2 (3%)                                                          
      Necrosis, Coagulative                           16 (27%)     26 (43%)     25 (42%)                                            
      Pigmentation                                                 54 (90%)     58 (97%)                                            
      Bile Duct, Hyperplasia                                        1 (2%)                                                          
      Bile Duct, Hyperplasia, Focal                                 1 (2%)                                                          
   Mesentery                                          (6)          (9)          (8)                                                 
      Fibrosis                                                      4 (44%)                                                         
      Inflammation, Chronic Active                     3 (50%)      5 (56%)      4 (50%)                                            
      Mineralization                                   1 (17%)                                                                      
      Necrosis, Coagulative                            1 (17%)      3 (33%)                                                         
      Pigmentation                                     1 (17%)                                                                      
   Pancreas                                           (60)         (60)         (59)                                                
      Atrophy                                                       1 (2%)       2 (3%)                                             
      Autolysis                                                                  2 (3%)                                             
      Cytoplasmic Alteration                           3 (5%)       1 (2%)                                                          
      Fibrosis                                                                   1 (2%)                                             
      Inflammation                                                  1 (2%)                                                          
      Inflammation, Chronic                            5 (8%)                    1 (2%)                                             
      Inflammation, Chronic Active                    25 (42%)     24 (40%)     18 (31%)                                            
      Vacuolization Cytoplasmic                       20 (33%)     13 (22%)     21 (36%)                                            
      Duct, Dilatation                                 1 (2%)       1 (2%)       1 (2%)                                             
      Duct, Hyperplasia                                             1 (2%)                                                          
   Salivary Glands                                    (59)         (60)         (57)                                                
      Inflammation, Chronic                                         1 (2%)       5 (9%)                                             
      Parotid Gland, Autolysis                                                   1 (2%)                                             
      Sublingual Gland, Inflammation, Chronic          1 (2%)       2 (3%)                                                          
      Submandibular Gland, Autolysis                                             1 (2%)                                             
      Submandibular Gland, Inflammation, Chronic      47 (80%)     32 (53%)     33 (58%)                                            
   Stomach, Forestomach                               (58)         (60)         (60)                                                
      Acanthosis                                       9 (16%)     16 (27%)     27 (45%)                                            
      Autolysis                                                                  1 (2%)                                             
      Erosion                                                       1 (2%)       1 (2%)                                             
      Hyperkeratosis                                  10 (17%)     16 (27%)     24 (40%)                                            
      Hyperplasia, Basal Cell                                       7 (12%)      5 (8%)                                             
      Hyperplasia, Squamous                                                      2 (3%)                                             
      Inflammation, Chronic                                                      2 (3%)                                             
      Inflammation, Chronic Active                     7 (12%)     11 (18%)     24 (40%)                                            
      Ulcer                                            2 (3%)       1 (2%)       2 (3%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05061-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  1-AMINO-2,4-DIBROMOANTHRAQUINONE                             Date: 05/19/95  
Route: DOSED FEED                                                                                                 Time: 16:49:58  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        UNTREATE     1.0%         2.0%                                                   
                                                   D 71UF       71LF         71HF                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Ulcer, Multiple                                  1 (2%)                                                                       
   Stomach, Glandular                                 (59)         (58)         (58)                                                
      Autolysis                                        2 (3%)                    1 (2%)                                             
      Inflammation, Chronic                            2 (3%)       1 (2%)       1 (2%)                                             
      Inflammation, Chronic Active                    21 (36%)     19 (33%)     21 (36%)                                            
      Mineralization                                   1 (2%)                    1 (2%)                                             
   Tooth                                              (1)                                                                           
      Abscess                                          1 (100%)                                                                     
      Dysplasia                                        1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (60)         (60)         (59)                                                
      Autolysis                                                                  1 (2%)                                             
      Cardiomyopathy                                   2 (3%)                                                                       
      Inflammation, Chronic                            9 (15%)      6 (10%)      8 (14%)                                            
      Mineralization                                                1 (2%)       1 (2%)                                             
      Thrombosis                                                    1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (60)         (59)         (58)                                                
      Angiectasis                                      2 (3%)                                                                       
      Autolysis                                                                  1 (2%)                                             
      Cyst                                                          1 (2%)                                                          
      Degeneration, Fatty                                                        1 (2%)                                             
      Hematopoietic Cell Proliferation                 1 (2%)       3 (5%)       1 (2%)                                             
      Hyperplasia                                                   1 (2%)       1 (2%)                                             
      Inflammation, Chronic Active                     2 (3%)       1 (2%)                                                          
      Vacuolization Cytoplasmic                                     1 (2%)                                                          
   Adrenal Medulla                                    (59)         (59)         (58)                                                
      Autolysis                                                                  1 (2%)                                             
      Hematopoietic Cell Proliferation                              1 (2%)       1 (2%)                                             
      Hyperplasia                                                   1 (2%)                                                          
   Islets, Pancreatic                                 (49)         (50)         (48)                                                
      Hyperplasia                                      3 (6%)       1 (2%)       1 (2%)                                             
   Parathyroid Gland                                  (43)         (49)         (43)                                                
      Cyst                                             1 (2%)                                                                       
   Pituitary Gland                                    (51)         (55)         (52)                                                
      Autolysis                                                                  1 (2%)                                             
      Pars Distalis, Angiectasis                       1 (2%)                                                                       
      Pars Distalis, Cyst                              3 (6%)                    1 (2%)                                             
      Pars Distalis, Hyperplasia                       8 (16%)     22 (40%)      8 (15%)                                            
      Pars Distalis, Pigmentation                      1 (2%)                                                                       
   Thyroid Gland                                      (60)         (60)         (58)                                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05061-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  1-AMINO-2,4-DIBROMOANTHRAQUINONE                             Date: 05/19/95  
Route: DOSED FEED                                                                                                 Time: 16:49:58  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        UNTREATE     1.0%         2.0%                                                   
                                                   D 71UF       71LF         71HF                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Autolysis                                                                  1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)       2 (3%)       3 (5%)                                             
      C-Cell, Hyperplasia                              1 (2%)       1 (2%)       1 (2%)                                             
      Follicle, Cyst                                   2 (3%)                    2 (3%)                                             
      Follicular Cell, Hyperplasia                     3 (5%)      19 (32%)     18 (31%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                                               (1)                                                 
      Duct, Dilatation                                                           1 (100%)                                           
   Ovary                                              (59)         (51)         (57)                                                
      Abscess                                                       3 (6%)       2 (4%)                                             
      Angiectasis                                      2 (3%)       4 (8%)       4 (7%)                                             
      Cyst                                            13 (22%)     12 (24%)      9 (16%)                                            
      Cyst, Multiple                                   1 (2%)       3 (6%)       1 (2%)                                             
      Hemorrhage                                                    1 (2%)                                                          
      Inflammation, Acute, Necrotizing                 1 (2%)                                                                       
      Mineralization                                                2 (4%)                                                          
      Pigmentation                                     1 (2%)                                                                       
      Periovarian Tissue, Cyst                         1 (2%)       2 (4%)                                                          
      Periovarian Tissue, Cyst, Multiple                                         1 (2%)                                             
      Periovarian Tissue, Hemorrhage                                             1 (2%)                                             
      Periovarian Tissue, Inflammation, Chronic        2 (3%)                                                                       
      Periovarian Tissue, Inflammation, Chronic                                                                                     
          Active                                      29 (49%)     24 (47%)     28 (49%)                                            
      Periovarian Tissue, Mineralization               1 (2%)                                                                       
      Periovarian Tissue, Pigmentation                                           1 (2%)                                             
   Uterus                                             (59)         (60)         (59)                                                
      Angiectasis                                                                1 (2%)                                             
      Fibrosis                                                      2 (3%)       1 (2%)                                             
      Hydrometra                                      22 (37%)      3 (5%)       3 (5%)                                             
      Inflammation, Acute                                           1 (2%)                                                          
      Inflammation, Chronic Active                     4 (7%)       6 (10%)      7 (12%)                                            
      Endometrium, Hyperplasia                        44 (75%)     36 (60%)     45 (76%)                                            
      Epithelium, Metaplasia, Squamous                 2 (3%)       1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05061-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  1-AMINO-2,4-DIBROMOANTHRAQUINONE                             Date: 05/19/95  
Route: DOSED FEED                                                                                                 Time: 16:49:58  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        UNTREATE     1.0%         2.0%                                                   
                                                   D 71UF       71LF         71HF                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (60)         (59)         (59)                                                
      Myelofibrosis                                    2 (3%)       5 (8%)       1 (2%)                                             
      Myeloid Cell, Sternal, Hyperplasia               2 (3%)       1 (2%)       2 (3%)                                             
      Sternal, Autolysis                                                         1 (2%)                                             
      Sternal, Myelofibrosis                          38 (63%)     32 (54%)     34 (58%)                                            
   Lymph Node                                         (7)          (12)         (12)                                                
      Lumbar, Hyperplasia, Lymphoid                    1 (14%)                   1 (8%)                                             
      Lumbar, Inflammation, Acute                      1 (14%)                                                                      
      Mediastinal, Hyperplasia, Lymphoid                                         1 (8%)                                             
      Mediastinal, Hyperplasia, Plasma Cell                                      1 (8%)                                             
      Mediastinal, Inflammation, Chronic Active        1 (14%)                                                                      
      Pancreatic, Hyperplasia, Lymphoid                             1 (8%)       1 (8%)                                             
      Pancreatic, Infiltration Cellular, Histiocyte                              1 (8%)                                             
      Pancreatic, Pigmentation                                                   1 (8%)                                             
      Renal, Hyperplasia, Plasma Cell                               2 (17%)                                                         
      Renal, Sinus, Ectasia                                                      1 (8%)                                             
   Lymph Node, Mandibular                             (38)         (55)         (41)                                                
      Autolysis                                                                  1 (2%)                                             
      Congestion                                       1 (3%)                                                                       
      Depletion Lymphoid                                            1 (2%)                                                          
      Hyperplasia, Lymphoid                            3 (8%)       1 (2%)       2 (5%)                                             
      Hyperplasia, Plasma Cell                         1 (3%)                    1 (2%)                                             
      Inflammation, Acute                                           1 (2%)                                                          
      Pigmentation                                     3 (8%)       2 (4%)       3 (7%)                                             
      Sinus, Ectasia                                                2 (4%)                                                          
   Lymph Node, Mesenteric                             (56)         (56)         (52)                                                
      Angiectasis                                      7 (13%)      4 (7%)       3 (6%)                                             
      Depletion Lymphoid                               2 (4%)       1 (2%)                                                          
      Hemorrhage                                                    2 (4%)                                                          
      Hyperplasia, Lymphoid                            2 (4%)       6 (11%)     10 (19%)                                            
      Infiltration Cellular, Histiocyte               36 (64%)     24 (43%)     34 (65%)                                            
      Inflammation, Chronic Active                     1 (2%)       3 (5%)       2 (4%)                                             
      Mineralization                                                1 (2%)                                                          
      Necrosis, Coagulative                            1 (2%)                                                                       
      Pigmentation                                    34 (61%)     24 (43%)     34 (65%)                                            
      Sinus, Ectasia                                                             1 (2%)                                             
   Spleen                                             (60)         (60)         (59)                                                
      Autolysis                                        1 (2%)                    1 (2%)                                             
      Depletion Lymphoid                               4 (7%)       2 (3%)       3 (5%)                                             
      Fibrosis                                         1 (2%)                                                                       
      Hematopoietic Cell Proliferation                 6 (10%)     13 (22%)     11 (19%)                                            
      Hyperplasia, Lymphoid                           15 (25%)     14 (23%)      8 (14%)                                            
      Inflammation, Chronic                            1 (2%)                                                                       
   Thymus                                             (49)         (48)         (42)                                                
      Angiectasis                                      1 (2%)                                                                       
      Cyst                                            20 (41%)     16 (33%)     28 (67%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05061-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  1-AMINO-2,4-DIBROMOANTHRAQUINONE                             Date: 05/19/95  
Route: DOSED FEED                                                                                                 Time: 16:49:58  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        UNTREATE     1.0%         2.0%                                                   
                                                   D 71UF       71LF         71HF                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Depletion Lymphoid                               4 (8%)       2 (4%)       6 (14%)                                            
      Hemorrhage                                                    1 (2%)       1 (2%)                                             
      Hyperplasia, Lymphoid                            3 (6%)       1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (35)         (35)         (30)                                                
      Hyperplasia                                      2 (6%)       9 (26%)      3 (10%)                                            
      Inflammation, Chronic                            1 (3%)                                                                       
   Skin                                               (60)         (60)         (60)                                                
      Acanthosis                                       1 (2%)                                                                       
      Autolysis                                                                  1 (2%)                                             
      Inflammation, Acute                              1 (2%)                                                                       
      Epidermis, Inflammation, Acute                                             1 (2%)                                             
      Subcutaneous Tissue, Cyst Epithelial                                                                                          
          Inclusion                                                 1 (2%)                                                          
      Subcutaneous Tissue, Fibrosis                                 1 (2%)                                                          
      Subcutaneous Tissue, Inflammation, Chronic                                                                                    
          Active                                       1 (2%)       2 (3%)       2 (3%)                                             
      Subcutaneous Tissue, Mineralization              1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (59)         (60)         (60)                                                
      Perivascular, Inflammation, Chronic                           1 (2%)                                                          
      Thalamus, Mineralization                        24 (41%)     15 (25%)     25 (42%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (60)         (60)         (59)                                                
      Autolysis                                                                  1 (2%)                                             
      Congestion                                       1 (2%)                                                                       
      Hemorrhage                                       4 (7%)       4 (7%)       8 (14%)                                            
      Infiltration Cellular, Histiocyte                                          1 (2%)                                             
      Inflammation, Chronic Active                     3 (5%)       4 (7%)       6 (10%)                                            
      Leukocytosis                                     1 (2%)       1 (2%)                                                          
      Alveolar Epithelium, Hyperplasia                                           1 (2%)                                             
      Pleura, Inflammation, Acute                                   1 (2%)                                                          
   Nose                                               (58)         (55)         (53)                                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05061-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  1-AMINO-2,4-DIBROMOANTHRAQUINONE                             Date: 05/19/95  
Route: DOSED FEED                                                                                                 Time: 16:49:58  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        UNTREATE     1.0%         2.0%                                                   
                                                   D 71UF       71LF         71HF                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Inflammation, Acute                             21 (36%)      9 (16%)      7 (13%)                                            
      Glands, Inflammation, Acute                      2 (3%)                    1 (2%)                                             
      Nasolacrimal Duct, Hyperplasia                   1 (2%)                                                                       
      Nasolacrimal Duct, Inflammation, Acute                        1 (2%)                                                          
   Trachea                                            (60)         (59)         (57)                                                
      Autolysis                                                                  1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)                       (1)                                                 
      Cornea, Inflammation, Chronic Active                                       1 (100%)                                           
      Cornea, Neovascularization                                                 1 (100%)                                           
   Harderian Gland                                    (1)          (3)          (2)                                                 
      Inflammation, Chronic                            1 (100%)                  2 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (60)         (54)         (60)                                                
      Autolysis                                                                  1 (2%)                                             
      Glomerulosclerosis                               2 (3%)       3 (6%)       4 (7%)                                             
      Hydronephrosis                                   1 (2%)       1 (2%)                                                          
      Infarct                                          1 (2%)                                                                       
      Inflammation, Chronic                           53 (88%)     46 (85%)     54 (90%)                                            
      Metaplasia, Osseous                                           3 (6%)       1 (2%)                                             
      Papilla, Mineralization                                                    1 (2%)                                             
      Pelvis, Transitional Epithelium, Hyperplasia                  1 (2%)                                                          
      Proximal Convoluted Renal Tubule,                                                                                             
          Degeneration, Hyaline                        1 (2%)                                                                       
      Renal Tubule, Atrophy                                         1 (2%)       3 (5%)                                             
      Renal Tubule, Casts Protein                      1 (2%)                                                                       
      Renal Tubule, Mineralization                                               3 (5%)                                             
      Renal Tubule, Pigmentation                                   43 (80%)     43 (72%)                                            
      Renal Tubule, Regeneration                       3 (5%)       7 (13%)      4 (7%)                                             
      Transitional Epithelium, Mineralization                                    1 (2%)                                             
   Urinary Bladder                                    (59)         (60)         (60)                                                
      Autolysis                                        3 (5%)       1 (2%)       2 (3%)                                             
      Inflammation, Chronic                            7 (12%)      7 (12%)      8 (13%)                                            
      Inflammation, Chronic Active                    42 (71%)     43 (72%)     46 (77%)                                            
      Arteriole, Necrosis, Fibrinoid                                             1 (2%)                                             
      Submucosa, Proliferation                         1 (2%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05061-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  1-AMINO-2,4-DIBROMOANTHRAQUINONE                             Date: 05/19/95  
Route: DOSED FEED                                                                                                 Time: 16:49:58  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATE     1.0%         2.0%                                                   
                                                   D 71UM       71LM         71HM                                                   
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           60           60                                                  
  Scheduled Sacrifice                                 10            9           10                                                  
  Early Deaths                                                                                                                      
    Moribund                                           7           23           21                                                  
    Dead                                               3            5            6                                                  
    Accident                                                        1                                                               
  Survivors                                                                                                                         
    Terminal Sacrifice                                40           22           23                                                  
  Animals Examined Microscopically                    60           60           60                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (56)         (56)         (51)                                                
      Autolysis                                        1 (2%)       2 (4%)                                                          
      Inflammation, Chronic                                                      1 (2%)                                             
      Inflammation, Chronic Active                    12 (21%)     12 (21%)      8 (16%)                                            
      Epithelium, Pigmentation                                      1 (2%)                                                          
   Intestine Large, Colon                             (60)         (58)         (60)                                                
      Autolysis                                        1 (2%)       2 (3%)                                                          
      Inflammation, Chronic Active                     1 (2%)       1 (2%)       2 (3%)                                             
      Peyer's Patch, Hyperplasia                       1 (2%)                                                                       
   Intestine Large, Rectum                            (58)         (58)         (58)                                                
      Autolysis                                        2 (3%)       2 (3%)                                                          
   Intestine Large, Cecum                             (59)         (60)         (60)                                                
      Autolysis                                        2 (3%)       2 (3%)                                                          
      Hemorrhage                                                    1 (2%)                                                          
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
      Ulcer, Acute                                     1 (2%)                                                                       
      Epithelium, Hyperplasia                                       1 (2%)                                                          
      Peyer's Patch, Hyperplasia                       1 (2%)       1 (2%)                                                          
      Serosa, Inflammation, Chronic Active                          1 (2%)                                                          
   Intestine Small, Duodenum                          (60)         (59)         (56)                                                
      Autolysis                                        2 (3%)       1 (2%)                                                          
      Mesothelium, Hyperplasia                                                   1 (2%)                                             
      Peyer's Patch, Inflammation, Chronic,                                                                                         
          Granulomatous                                             1 (2%)                                                          
      Serosa, Fibrosis                                                           1 (2%)                                             
   Intestine Small, Jejunum                           (60)         (56)         (58)                                                
      Autolysis                                        2 (3%)       1 (2%)                                                          
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
      Inflammation, Acute                                           1 (2%)                                                          
      Epithelium, Pigmentation                                                   1 (2%)                                             
      Peyer's Patch, Inflammation, Chronic,                                                                                         
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05061-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  1-AMINO-2,4-DIBROMOANTHRAQUINONE                             Date: 05/19/95  
Route: DOSED FEED                                                                                                 Time: 16:49:58  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATE     1.0%         2.0%                                                   
                                                   D 71UM       71LM         71HM                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
          Granulomatous                                             1 (2%)                                                          
   Intestine Small, Ileum                             (60)         (58)         (57)                                                
      Autolysis                                        2 (3%)       1 (2%)                                                          
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
      Inflammation, Acute, Necrotizing                 1 (2%)                                                                       
      Inflammation, Chronic Active                                               1 (2%)                                             
      Peyer's Patch, Hyperplasia                       1 (2%)       2 (3%)       1 (2%)                                             
      Peyer's Patch, Hyperplasia, Lymphoid             1 (2%)                                                                       
      Peyer's Patch, Inflammation, Chronic,                                                                                         
          Granulomatous                                             1 (2%)                                                          
   Liver                                              (60)         (60)         (60)                                                
      Angiectasis                                      1 (2%)                                                                       
      Basophilic Focus                                              4 (7%)       4 (7%)                                             
      Basophilic Focus, Focal                                                    1 (2%)                                             
      Clear Cell Focus                                 4 (7%)       4 (7%)       2 (3%)                                             
      Cytoplasmic Alteration                           1 (2%)                                                                       
      Eosinophilic Focus                                            6 (10%)      1 (2%)                                             
      Fatty Change                                    11 (18%)      6 (10%)      7 (12%)                                            
      Fibrosis                                                      1 (2%)                                                          
      Hematopoietic Cell Proliferation                 1 (2%)       5 (8%)      10 (17%)                                            
      Infarct                                                                    1 (2%)                                             
      Inflammation, Acute                              1 (2%)       9 (15%)      3 (5%)                                             
      Inflammation, Chronic Active                    15 (25%)     10 (17%)     27 (45%)                                            
      Karyomegaly                                                                1 (2%)                                             
      Mineralization                                   1 (2%)       1 (2%)                                                          
      Necrosis, Coagulative                            9 (15%)     20 (33%)     28 (47%)                                            
      Nuclear Alteration                                            1 (2%)                                                          
      Pigmentation                                     1 (2%)      59 (98%)     57 (95%)                                            
      Thrombosis                                                                 1 (2%)                                             
      Bile Duct, Hyperplasia                           1 (2%)       2 (3%)       1 (2%)                                             
      Centrilobular, Cytoplasmic Alteration                         9 (15%)      8 (13%)                                            
      Hepatocyte, Centrilobular, Hypertrophy                       17 (28%)     13 (22%)                                            
   Mesentery                                          (2)          (8)          (9)                                                 
      Abscess                                                                    1 (11%)                                            
      Fibrosis                                                                   1 (11%)                                            
      Inflammation, Chronic                                         1 (13%)                                                         
      Inflammation, Chronic Active                                  4 (50%)      5 (56%)                                            
      Mineralization                                                             1 (11%)                                            
      Necrosis, Coagulative                                         1 (13%)      2 (22%)                                            
      Thrombosis                                                    1 (13%)                                                         
   Pancreas                                           (60)         (59)         (58)                                                
      Atrophy                                          2 (3%)                    1 (2%)                                             
      Autolysis                                        1 (2%)       1 (2%)                                                          
      Cytoplasmic Alteration                           4 (7%)                    2 (3%)                                             
      Ectopic Liver                                                 1 (2%)                                                          
      Inflammation, Chronic                            2 (3%)                                                                       
      Inflammation, Chronic Active                    19 (32%)     12 (20%)      8 (14%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05061-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  1-AMINO-2,4-DIBROMOANTHRAQUINONE                             Date: 05/19/95  
Route: DOSED FEED                                                                                                 Time: 16:49:58  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATE     1.0%         2.0%                                                   
                                                   D 71UM       71LM         71HM                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Vacuolization Cytoplasmic                       20 (33%)     18 (31%)      4 (7%)                                             
      Acinus, Atrophy                                               1 (2%)                                                          
      Artery, Inflammation, Chronic Active                                       1 (2%)                                             
   Salivary Glands                                    (60)         (59)         (60)                                                
      Inflammation, Chronic                            2 (3%)                                                                       
      Duct, Parotid Gland, Mineralization                                        1 (2%)                                             
      Parotid Gland, Inflammation, Chronic             2 (3%)                                                                       
      Sublingual Gland, Inflammation, Chronic                       1 (2%)                                                          
      Sublingual Gland, Submandibular Gland,                                                                                        
          Inflammation, Chronic                                                  1 (2%)                                             
      Submandibular Gland, Atrophy                                               1 (2%)                                             
      Submandibular Gland, Inflammation, Chronic      45 (75%)     29 (49%)     40 (67%)                                            
   Stomach, Forestomach                               (59)         (59)         (60)                                                
      Abscess                                                       1 (2%)                                                          
      Acanthosis                                       1 (2%)      11 (19%)      7 (12%)                                            
      Autolysis                                        1 (2%)                                                                       
      Cyst                                                          1 (2%)                                                          
      Diverticulum                                                  1 (2%)                                                          
      Edema                                            1 (2%)                                                                       
      Erosion                                          1 (2%)                                                                       
      Hyperkeratosis                                   2 (3%)       9 (15%)      9 (15%)                                            
      Hyperplasia, Basal Cell                                       1 (2%)       3 (5%)                                             
      Inflammation, Acute                                                        1 (2%)                                             
      Inflammation, Chronic Active                     2 (3%)       6 (10%)     14 (23%)                                            
      Inflammation, Chronic Active, Necrotizing                                  1 (2%)                                             
      Ulcer                                                         2 (3%)                                                          
   Stomach, Glandular                                 (59)         (59)         (59)                                                
      Autolysis                                        1 (2%)                                                                       
      Edema                                                                      1 (2%)                                             
      Infiltration Cellular, Mast Cell                              1 (2%)                                                          
      Inflammation, Chronic                            1 (2%)       5 (8%)       2 (3%)                                             
      Inflammation, Chronic Active                    15 (25%)     24 (41%)     23 (39%)                                            
      Mineralization                                   4 (7%)                    3 (5%)                                             
      Muscularis, Mineralization                                    1 (2%)                                                          
   Tooth                                              (4)                       (7)                                                 
      Dysplasia                                        4 (100%)                  6 (86%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (60)         (60)         (60)                                                
      Cardiomyopathy                                   3 (5%)                    1 (2%)                                             
      Inflammation, Chronic                            7 (12%)     17 (28%)      5 (8%)                                             
      Mineralization                                   1 (2%)                                                                       
      Necrosis, Coagulative                                         1 (2%)                                                          
      Coronary Artery, Thrombosis                                   1 (2%)                                                          
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05061-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  1-AMINO-2,4-DIBROMOANTHRAQUINONE                             Date: 05/19/95  
Route: DOSED FEED                                                                                                 Time: 16:49:58  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATE     1.0%         2.0%                                                   
                                                   D 71UM       71LM         71HM                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (60)         (60)         (60)                                                
      Hematopoietic Cell Proliferation                              1 (2%)                                                          
      Hyperplasia                                                   3 (5%)       2 (3%)                                             
      Inflammation, Chronic Active                     3 (5%)                                                                       
      Pigmentation                                     2 (3%)                                                                       
      Vacuolization Cytoplasmic                                                  1 (2%)                                             
      Capsule, Inflammation, Chronic Active                                      1 (2%)                                             
   Adrenal Medulla                                    (60)         (59)         (60)                                                
      Hyperplasia                                      1 (2%)       1 (2%)                                                          
      Inflammation, Acute                              1 (2%)                                                                       
      Pigmentation                                                  1 (2%)                                                          
   Islets, Pancreatic                                 (51)         (50)         (49)                                                
      Hyperplasia                                      9 (18%)      1 (2%)       1 (2%)                                             
      Inflammation, Chronic                                                      1 (2%)                                             
   Pituitary Gland                                    (52)         (54)         (56)                                                
      Pars Distalis, Cyst                              5 (10%)      4 (7%)       1 (2%)                                             
      Pars Distalis, Hyperplasia                      13 (25%)      9 (17%)      6 (11%)                                            
   Thyroid Gland                                      (59)         (59)         (59)                                                
      Inflammation, Chronic                            1 (2%)       1 (2%)       1 (2%)                                             
      Ultimobranchial Cyst                             1 (2%)       1 (2%)                                                          
      Follicle, Cyst                                                             1 (2%)                                             
      Follicular Cell, Hyperplasia                     2 (3%)       3 (5%)       3 (5%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Coagulating Gland                                  (1)          (1)          (1)                                                 
      Inflammation, Chronic Active                                               1 (100%)                                           
   Epididymis                                         (59)         (60)         (60)                                                
      Inflammation, Chronic Active                    30 (51%)     21 (35%)     26 (43%)                                            
      Epithelium, Hyperplasia                                       1 (2%)                                                          
      Serosa, Hyperplasia                                                        1 (2%)                                             
   Penis                                              (1)          (1)          (2)                                                 
      Hemorrhage                                                    1 (100%)                                                        
      Inflammation, Acute                              1 (100%)                                                                     
   Preputial Gland                                    (21)         (16)         (13)                                                
      Abscess                                          1 (5%)       3 (19%)      2 (15%)                                            
      Inflammation, Chronic                            2 (10%)                                                                      
      Inflammation, Chronic Active                    14 (67%)      7 (44%)     11 (85%)                                            
      Duct, Dilatation                                12 (57%)     10 (63%)      2 (15%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05061-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  1-AMINO-2,4-DIBROMOANTHRAQUINONE                             Date: 05/19/95  
Route: DOSED FEED                                                                                                 Time: 16:49:58  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATE     1.0%         2.0%                                                   
                                                   D 71UM       71LM         71HM                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
   Prostate                                           (57)         (55)         (57)                                                
      Inflammation                                                  1 (2%)                                                          
      Inflammation, Chronic                            5 (9%)                    2 (4%)                                             
      Inflammation, Chronic Active                    32 (56%)     29 (53%)     20 (35%)                                            
      Artery, Inflammation, Chronic Active             1 (2%)                                                                       
      Epithelium, Hyperplasia                          1 (2%)                                                                       
   Seminal Vesicle                                    (59)         (59)         (55)                                                
      Atrophy                                                       1 (2%)       1 (2%)                                             
      Cyst                                                          1 (2%)                                                          
      Fibrosis                                                      3 (5%)                                                          
      Inflammation, Chronic Active                     4 (7%)      14 (24%)     13 (24%)                                            
      Artery, Thrombosis                                            1 (2%)                                                          
   Testes                                             (60)         (59)         (60)                                                
      Atrophy                                                                    2 (3%)                                             
      Inflammation, Chronic Active                                               2 (3%)                                             
      Interstitial Cell, Hyperplasia                                1 (2%)                                                          
      Seminiferous Tubule, Atrophy                     7 (12%)                   4 (7%)                                             
      Seminiferous Tubule, Mineralization              2 (3%)       1 (2%)       3 (5%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (59)         (59)         (59)                                                
      Myeloid Cell, Sternal, Hyperplasia               1 (2%)       2 (3%)       1 (2%)                                             
      Sternal, Infiltration Cellular, Mast Cell        1 (2%)                                                                       
      Sternal, Inflammation, Granulomatous                          1 (2%)                                                          
   Lymph Node                                         (10)         (8)          (11)                                                
      Hyperplasia, Lymphoid                                                      1 (9%)                                             
      Inguinal, Hyperplasia, Lymphoid                  1 (10%)                                                                      
      Lumbar, Hyperplasia                              1 (10%)                                                                      
      Lumbar, Hyperplasia, Lymphoid                    1 (10%)      1 (13%)                                                         
      Lumbar, Hyperplasia, Plasma Cell                                           2 (18%)                                            
      Lumbar, Inflammation, Chronic Active                          1 (13%)                                                         
      Mediastinal, Infiltration Cellular,                                                                                           
          Histiocyte                                                1 (13%)                                                         
      Mediastinal, Inflammation, Chronic Active                                  1 (9%)                                             
      Mediastinal, Pigmentation                                     1 (13%)                                                         
      Pancreatic, Angiectasis                                                    1 (9%)                                             
      Pancreatic, Hyperplasia, Lymphoid                2 (20%)                                                                      
      Pancreatic, Infiltration Cellular, Histiocyte    1 (10%)                                                                      
      Pancreatic, Pigmentation                         1 (10%)                                                                      
      Renal, Angiectasis                               1 (10%)                                                                      
      Renal, Hyperplasia, Lymphoid                     1 (10%)                                                                      
      Renal, Inflammation, Chronic Active                           1 (13%)                                                         
   Lymph Node, Mandibular                             (38)         (43)         (36)                                                
      Depletion Lymphoid                               3 (8%)       1 (2%)       1 (3%)                                             
      Hyperplasia, Lymphoid                            3 (8%)       1 (2%)       1 (3%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
NTP Experiment-Test: 05061-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  1-AMINO-2,4-DIBROMOANTHRAQUINONE                             Date: 05/19/95  
Route: DOSED FEED                                                                                                 Time: 16:49:58  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATE     1.0%         2.0%                                                   
                                                   D 71UM       71LM         71HM                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Hyperplasia, Plasma Cell                                      1 (2%)                                                          
      Infiltration Cellular, Histiocyte                3 (8%)                    8 (22%)                                            
      Inflammation, Chronic Active                     1 (3%)       1 (2%)       1 (3%)                                             
      Necrosis, Coagulative                                                      1 (3%)                                             
      Pigmentation                                     5 (13%)      4 (9%)       9 (25%)                                            
   Lymph Node, Mesenteric                             (54)         (56)         (55)                                                
      Angiectasis                                     24 (44%)     11 (20%)     21 (38%)                                            
      Congestion                                                    1 (2%)                                                          
      Depletion Lymphoid                               1 (2%)                    1 (2%)                                             
      Hematopoietic Cell Proliferation                              2 (4%)                                                          
      Hemorrhage                                       1 (2%)                    4 (7%)                                             
      Hyperplasia                                                                1 (2%)                                             
      Hyperplasia, Lymphoid                            6 (11%)      9 (16%)      4 (7%)                                             
      Hyperplasia, Plasma Cell                                      1 (2%)                                                          
      Infiltration Cellular, Histiocyte               24 (44%)     22 (39%)     22 (40%)                                            
      Inflammation, Chronic Active                                  7 (13%)      4 (7%)                                             
      Pigmentation                                    23 (43%)     22 (39%)     20 (36%)                                            
   Spleen                                             (60)         (60)         (58)                                                
      Angiectasis                                      1 (2%)                                                                       
      Congestion                                                                 1 (2%)                                             
      Depletion Lymphoid                               1 (2%)       3 (5%)       3 (5%)                                             
      Fibrosis                                                                   1 (2%)                                             
      Hematopoietic Cell Proliferation                 6 (10%)     14 (23%)     12 (21%)                                            
      Hyperplasia, Lymphoid                                         2 (3%)       1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)       1 (2%)       2 (3%)                                             
      Necrosis, Coagulative                                         1 (2%)                                                          
   Thymus                                             (44)         (44)         (41)                                                
      Cyst                                             2 (5%)       6 (14%)     12 (29%)                                            
      Cyst, Multiple                                   2 (5%)                                                                       
      Depletion Lymphoid                               2 (5%)       8 (18%)      6 (15%)                                            
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
      Infiltration Cellular, Histiocyte                             1 (2%)                                                          
      Necrosis, Coagulative                                         1 (2%)       1 (2%)                                             
      Pigmentation                                     1 (2%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (60)         (57)         (58)                                                
      Inflammation, Acute                              1 (2%)                                                                       
      Inflammation, Chronic Active                     4 (7%)       9 (16%)     13 (22%)                                            
      Subcutaneous Tissue, Abscess                                               1 (2%)                                             
      Subcutaneous Tissue, Cyst                                     1 (2%)                                                          
      Subcutaneous Tissue, Fibrosis                                 2 (4%)       1 (2%)                                             
      Subcutaneous Tissue, Inflammation, Acute         2 (3%)                                                                       
      Subcutaneous Tissue, Inflammation, Chronic                                                                                    
          Active                                                                 1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   14                                                              
NTP Experiment-Test: 05061-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  1-AMINO-2,4-DIBROMOANTHRAQUINONE                             Date: 05/19/95  
Route: DOSED FEED                                                                                                 Time: 16:49:58  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATE     1.0%         2.0%                                                   
                                                   D 71UM       71LM         71HM                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (51)         (52)         (59)                                                
      Cartilage, Tarsal, Hyperplasia                   1 (2%)                                                                       
      Joint, Tarsal, Hyperostosis                     12 (24%)     13 (25%)     12 (20%)                                            
   Skeletal Muscle                                    (3)          (3)          (3)                                                 
      Fibrosis                                         1 (33%)                                                                      
      Intercostal, Inflammation, Chronic Active                                  1 (33%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (60)         (60)         (60)                                                
      Cyst Epithelial Inclusion                                                  1 (2%)                                             
      Cerebellum, Necrosis                             1 (2%)                                                                       
      Cerebrum, Necrosis                               1 (2%)                                                                       
      Thalamus, Mineralization                        26 (43%)     20 (33%)     19 (32%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (60)         (60)         (60)                                                
      Bronchiectasis                                                1 (2%)                                                          
      Congestion                                       1 (2%)                    1 (2%)                                             
      Crystals                                                      1 (2%)                                                          
      Foreign Body                                                  1 (2%)                                                          
      Granuloma                                                     1 (2%)                                                          
      Hemorrhage                                       9 (15%)      9 (15%)     10 (17%)                                            
      Infiltration Cellular, Histiocyte                2 (3%)       2 (3%)       6 (10%)                                            
      Inflammation, Acute                                           2 (3%)                                                          
      Inflammation, Chronic Active                     1 (2%)       3 (5%)       1 (2%)                                             
      Mineralization                                   1 (2%)                                                                       
      Pigmentation                                                               1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 1 (2%)                    4 (7%)                                             
      Bronchiole, Hyperplasia                          1 (2%)                                                                       
      Bronchiole, Metaplasia, Squamous                              1 (2%)                                                          
      Peribronchiolar, Inflammation, Chronic           1 (2%)                                                                       
      Perivascular, Inflammation, Chronic              1 (2%)                                                                       
   Nose                                               (53)         (58)         (58)                                                
      Crystals                                         1 (2%)                                                                       
      Inflammation, Acute                             13 (25%)     11 (19%)      6 (10%)                                            
      Glands, Crystals                                 2 (4%)                                                                       
      Glands, Inflammation, Acute                                                2 (3%)                                             
      Nasolacrimal Duct, Inflammation, Acute           2 (4%)                                                                       
      Respiratory Epithelium, Necrosis                                           1 (2%)                                             
   Trachea                                            (60)         (59)         (60)                                                
      Inflammation, Acute                              2 (3%)                    3 (5%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   15                                                              
NTP Experiment-Test: 05061-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  1-AMINO-2,4-DIBROMOANTHRAQUINONE                             Date: 05/19/95  
Route: DOSED FEED                                                                                                 Time: 16:49:58  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATE     1.0%         2.0%                                                   
                                                   D 71UM       71LM         71HM                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (2)          (1)                                                              
      Anterior, Synechia                                            1 (100%)                                                        
      Cornea, Fibrosis                                              1 (100%)                                                        
      Cornea, Inflammation, Chronic Active             1 (50%)                                                                      
   Harderian Gland                                    (2)          (2)          (1)                                                 
      Inflammation, Chronic Active                     1 (50%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (60)         (52)         (60)                                                
      Autolysis                                                     1 (2%)                                                          
      Congestion                                                    1 (2%)                                                          
      Cyst                                             1 (2%)                    1 (2%)                                             
      Glomerulosclerosis                                            3 (6%)                                                          
      Infiltration Cellular, Mononuclear Cell                       1 (2%)                                                          
      Inflammation, Acute, Necrotizing                                           1 (2%)                                             
      Inflammation, Chronic                           10 (17%)      1 (2%)       8 (13%)                                            
      Inflammation, Chronic Active                    47 (78%)     42 (81%)     47 (78%)                                            
      Metaplasia, Osseous                                                        1 (2%)                                             
      Mineralization                                                             1 (2%)                                             
      Necrosis, Coagulative                                         1 (2%)                                                          
      Artery, Necrosis, Fibrinoid                                   1 (2%)                                                          
      Pelvis, Transitional Epithelium, Hyperplasia                  1 (2%)                                                          
      Proximal Convoluted Renal Tubule, Hyperplasia                 1 (2%)                                                          
      Proximal Convoluted Renal Tubule,                                                                                             
          Regeneration                                 2 (3%)      11 (21%)      1 (2%)                                             
      Proximal Convoluted Renal Tubule,                                                                                             
          Vacuolization Cytoplasmic                    1 (2%)                                                                       
      Renal Tubule, Mineralization                     1 (2%)       4 (8%)       1 (2%)                                             
      Renal Tubule, Pigmentation                                   42 (81%)     43 (72%)                                            
      Renal Tubule, Regeneration                       4 (7%)       1 (2%)       4 (7%)                                             
   Urinary Bladder                                    (59)         (59)         (59)                                                
      Autolysis                                        2 (3%)       3 (5%)                                                          
      Calculus Micro Observation Only                  5 (8%)       2 (3%)                                                          
      Inflammation, Chronic                            3 (5%)       7 (12%)      5 (8%)                                             
      Inflammation, Chronic Active                    37 (63%)     31 (53%)     34 (58%)                                            
      Transitional Epithelium, Hyperplasia                          2 (3%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   16                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------                                           

--multipart-boundary
Content-type: text/plain
Range: bytes 114197-114197/114197


--multipart-boundary--